Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Silence Therapeutics FY EPS $(0.33) Up From $(0.49) YoY, Sales $43.26M Up From $31.64M YoY

Author: Benzinga Newsdesk | February 27, 2025 09:24am
Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.33) per share. This is a 32.65 percent increase over losses of $(0.49) per share from the same period last year. The company reported $43.26 million in sales this quarter. This is a 36.71 percent increase over sales of $31.64 million the same period last year.

Posted In: SLN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist